Chronic Idiopathic Constipation Treatment Market by Type and Drugs- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 152 Category: Pharma & Healthcare Report Code : HC0115011
Chronic Idiopathic Constipation Treatment Market By Type (Normal-transit constipation, Slow-transit constipation and Others) and Drugs (Serotonin-4 (5-Ht4) Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants and Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Chronic Idiopathic Constipation Treatment Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Chronic Idiopathic Constipation sometimes happens because the muscles that help to pass the stool stop working well. Many drugsworks by turning on switches in the cells that tell more fluid to come into the gastrointestinal tract.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Chronic Idiopathic Constipation Treatment Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- ALLERGAN
- Mallinckrodt plc
- Synergy Pharmaceuticals Inc
- Shandong Luoxin Pharmaceutical Group Stock co., ltd
- Takeda Pharmaceutical Company Limited
- Sanofi
- ZydusCadila
- BoehringerIngelheim International GmbH
- Shreya Life Sciences Pvt Ltd
- Abbott
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Chronic Idiopathic Constipation Treatment Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Normal-transit constipation
o Slow-transit constipation
o Others
· Chronic Idiopathic Constipation Treatment Market, ByDrugs, Estimates and Forecast, 2017-2027 ($Million)
o Serotonin-4 (5-Ht4) Receptor Agonist
o Guanylate Cyclase-C Agonist
o Laxatives
o Stimulants
o Others
· Chronic Idiopathic Constipation Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o ALLERGAN
o Mallinckrodt plc
o Synergy Pharmaceuticals Inc
o Shandong Luoxin Pharmaceutical Group Stock co., ltd
o Takeda Pharmaceutical Company Limited
o Sanofi
o ZydusCadila
o BoehringerIngelheim International GmbH
o Shreya Life Sciences Pvt Ltd
o Abbott
· Chronic Idiopathic Constipation Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Chronic Idiopathic Constipation Treatment Market, By Country
o U.S. Chronic Idiopathic Constipation Treatment Market
o Canada Chronic Idiopathic Constipation Treatment Market
o Mexico Chronic Idiopathic Constipation Treatment Market
o Europe
§ Europe Chronic Idiopathic Constipation Treatment Market, By Country
o UK Chronic Idiopathic Constipation Treatment Market
o Germany Chronic Idiopathic Constipation Treatment Market
o France Chronic Idiopathic Constipation Treatment Market
o Russia Chronic Idiopathic Constipation Treatment Market
o Italy Chronic Idiopathic Constipation Treatment Market
o Rest of Europe Chronic Idiopathic Constipation Treatment Market
o Asia-Pacific
§ Asia-Pacific Chronic Idiopathic Constipation Treatment Market, By Country
o China Chronic Idiopathic Constipation Treatment Market
o Japan Chronic Idiopathic Constipation Treatment Market
o South Korea Chronic Idiopathic Constipation Treatment Market
o India Chronic Idiopathic Constipation Treatment Market
o Southeast Asia Chronic Idiopathic Constipation Treatment Market
o Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Market
o South America
§ South America Chronic Idiopathic Constipation Treatment Market
o Brazil Chronic Idiopathic Constipation Treatment Market
o Argentina Chronic Idiopathic Constipation Treatment Market
o Columbia Chronic Idiopathic Constipation Treatment Market
o Rest of South America Chronic Idiopathic Constipation Treatment Market
o Middle East and Africa
§ Middle East and Africa Chronic Idiopathic Constipation Treatment Market
o Saudi Arabia Chronic Idiopathic Constipation Treatment Market
o UAE Chronic Idiopathic Constipation Treatment Market
o Egypt Chronic Idiopathic Constipation Treatment Market
o Nigeria Chronic Idiopathic Constipation Treatment Market
o South Africa Chronic Idiopathic Constipation Treatment Market
o TurkeyChronic Idiopathic Constipation Treatment Market
o Rest of MEA Chronic Idiopathic Constipation Treatment Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Chronic Idiopathic Constipation Treatment Market, By Type
5.1. Introduction
5.2. Global Chronic Idiopathic Constipation Treatment Revenue and Market Share by Type (2017-2021)
5.2.1. Global Chronic Idiopathic Constipation Treatment Revenue and Revenue Share by Type (2017-2021)
5.3. Normal-transit constipation
5.3.1. Global Normal-transit constipation Revenue and Growth Rate (2017-2021)
5.4. Slow-transit constipation
5.4.1. Global Slow-transit constipation Revenue and Growth Rate (2017-2021)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2021)
6. Chronic Idiopathic Constipation Treatment Market, By Drugs
6.1. Introduction
6.2. Global Chronic Idiopathic Constipation Treatment Revenue and Market Share by Drugs (2017-2021)
6.2.1. Global Chronic Idiopathic Constipation Treatment Revenue and Revenue Share by Drugs (2017-2021)
6.3. Serotonin-4 (5-Ht4) Receptor Agonist
6.3.1. Global Serotonin-4 (5-Ht4) Receptor Agonist Revenue and Growth Rate (2017-2021)
6.4. Guanylate Cyclase-C Agonist
6.4.1. Global Guanylate Cyclase-C Agonist Revenue and Growth Rate (2017-2021)
6.5. Laxatives
6.5.1. Global Laxatives Revenue and Growth Rate (2017-2021)
6.6. Stimulants
6.6.1. Global Stimulants Revenue and Growth Rate (2017-2021)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2021)
7. Chronic Idiopathic Constipation Treatment Market, By Region
7.1. Introduction
7.2. Global Chronic Idiopathic Constipation Treatment Revenue and Market Share by Regions
7.2.1. Global Chronic Idiopathic Constipation Treatment Revenue by Regions (2017-2021)
7.3. North America Chronic Idiopathic Constipation Treatment by Countries
7.3.1. North America Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2021)
7.3.2. North America Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Chronic Idiopathic Constipation Treatment by Countries
7.4.1. Europe Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2021)
7.4.2. Europe Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Chronic Idiopathic Constipation Treatment by Countries
7.5.1. Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Chronic Idiopathic Constipation Treatment by Countries
7.6.1. South America Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2021)
7.6.2. South America Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Chronic Idiopathic Constipation Treatment by Countries
7.7.1. Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. ALLERGAN
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Mallinckrodt plc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Synergy Pharmaceuticals Inc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Shandong Luoxin Pharmaceutical Group Stock co., ltd
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Takeda Pharmaceutical Company Limited
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Sanofi
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Zydus Cadila
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Boehringer Ingelheim International GmbH
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Shreya Life Sciences Pvt Ltd
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Abbott
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.1. Global Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Chronic Idiopathic Constipation Treatment Market Forecast by Regions (2022-2027)
9.2.1. North America Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.1.1. United States Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.1.2. Canada Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.1.3. Mexico Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2. Europe Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.1. Germany Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.2. France Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.3. UK Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.4. Russia Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.5. Italy Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.1. China Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.2. Japan Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.3. Korea Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.4. India Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.4. South America Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.4.1. Brazil Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.4.2. Argentina Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.4.3. Columbia Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.4.4. Rest of South America Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5. Middle East and Africa Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.3. Egypt Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.4. Nigeria Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.5. South Africa Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.6. Turkey Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Market Forecast (2022-2027)
9.3. Chronic Idiopathic Constipation Treatment Market Forecast by Type (2022-2027)
9.3.1. Chronic Idiopathic Constipation Treatment Forecast by Type (2022-2027)
9.3.2. Chronic Idiopathic Constipation Treatment Market Share Forecast by Type (2022-2027)
9.4. Chronic Idiopathic Constipation Treatment Market Forecast by Drugs (2022-2027)
9.4.1. Chronic Idiopathic Constipation Treatment Forecast by Drugs (2022-2027)
9.4.2. Chronic Idiopathic Constipation Treatment Market Share Forecast by Drugs (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Chronic Idiopathic Constipation Treatment Revenue and Revenue Share by Type (2017-2019)
Figure Global Normal-transit constipation Revenue and Growth Rate (2017-2019)
Figure Global Slow-transit constipation Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Chronic Idiopathic Constipation Treatment Revenue and Revenue Share by Drugs (2017-2019)
Figure Global Serotonin-4 (5-Ht4) Receptor Agonist Revenue and Growth Rate (2017-2019)
Figure Global Guanylate Cyclase-C Agonist Revenue and Growth Rate (2017-2019)
Figure Global Laxatives Revenue and Growth Rate (2017-2019)
Figure Global Stimulants Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Chronic Idiopathic Constipation Treatment Revenue by Regions (2017-2019)
Figure North America Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure North America Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2019)
Figure North America Chronic Idiopathic Constipation Treatment by Countries (2017-2019)
Figure North America Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2019)
Figure United States Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure United States Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Canada Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Mexico Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Europe Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2019)
Figure Europe Chronic Idiopathic Constipation Treatment by Countries (2017-2019)
Figure Europe Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Germany Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Germany Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure France Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure UK Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Russia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Italy Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Rest of Europe Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Chronic Idiopathic Constipation Treatment by Countries (2017-2019)
Figure Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2019)
Figure China Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure China Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Japan Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Korea Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure India Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Southeast Asia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure South America Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2019)
Figure South America Chronic Idiopathic Constipation Treatment by Countries (2017-2019)
Figure South America Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Brazil Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Argentina Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Columbia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Rest of South America Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Chronic Idiopathic Constipation Treatment by Countries (2017-2019)
Figure Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Saudi Arabia Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure United Arab Emirates Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Egypt Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Nigeria Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure South Africa Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Turkey Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Table ALLERGAN Chronic Idiopathic Constipation Treatment Financial Overview
Table Mallinckrodt plc Chronic Idiopathic Constipation Treatment Financial Overview
Table Synergy Pharmaceuticals Inc Chronic Idiopathic Constipation Treatment Financial Overview
Table Shandong Luoxin Pharmaceutical Group Stock co., ltd Chronic Idiopathic Constipation Treatment Financial Overview
Table Takeda Pharmaceutical Company Limited Chronic Idiopathic Constipation Treatment Financial Overview
Table Sanofi Chronic Idiopathic Constipation Treatment Financial Overview
Table Zydus Cadila Chronic Idiopathic Constipation Treatment Financial Overview
Table Boehringer Ingelheim International GmbH Chronic Idiopathic Constipation Treatment Financial Overview
Table Shreya Life Sciences Pvt Ltd Chronic Idiopathic Constipation Treatment Financial Overview
Table Abbott Chronic Idiopathic Constipation Treatment Financial Overview
Figure Global Chronic Idiopathic Constipation Treatment Revenue (Millions USD) and Growth Rate (2019-2027)
Table Chronic Idiopathic Constipation Treatment Market Forecast by Regions (2019-2027)
Figure North America Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure United States Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Canada Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Mexico Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Europe Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Germany Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure France Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure UK Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Russia Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Italy Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Rest of Europe Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Asia-Pacific Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure China Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Japan Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Korea Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure India Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Southeast Asia Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure South America Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Brazil Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Argentina Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Columbia Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Rest of South America Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Middle East and Africa Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Saudi Arabia Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure United Arab Emirates Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Egypt Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Nigeria Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure South Africa Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Turkey Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Chronic Idiopathic Constipation Treatment Market Forecast (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Forecast by Type (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Market Share Forecast by Type (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Forecast by Type (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Forecast by Drugs (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Market Share Forecast by Drugs (2019-2027)
Figure Global Chronic Idiopathic Constipation Treatment Forecast by Drugs (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|